Your session is about to expire
← Back to Search
Exercise + Nicotinamide Riboside for Cancer Survivors with Insulin Resistance
Study Summary
This trial is testing the effect of exercise and nicotinamide riboside (a supplement similar to vitamin B3) on muscle health and insulin resistance in adult survivors of childhood cancer. The results may help develop regimens to improve these outcomes in future survivors.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Arm I (home exercise)
- Group 2: Arm II (home exercise, nicotinamide riboside)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
How many individuals has the study recruited thus far?
"Yes, current information on clinicaltrials.gov confirms the active recruitment of participants for this project which was first posted on June 23rd 2022. The last update was done at the end of that month with a goal to enroll 20 patients from one site."
Are recruitment efforts ongoing for this research project?
"As per the clinicaltrials.gov listing, this investigation is currently recruiting patients. This trial was first made public on June 23rd 2022 and its details have since been updated as recently as June 30th 2022."
Share this study with friends
Copy Link
Messenger